Profiel
Steven Glazer is currently the Chief Medical Officer at MonTa Biosciences ApS, Allero Therapeutics BV, and Glazer Consulting Holding ApS.
Previously, he worked as the Medical Director at Novo Nordisk Scandinavia AB, Independent Director at Mendus AB, Medical Director at RhoVac AB, Senior Vice President-Development at BioInvent International AB, Vice President-Development at Zealand Pharma A, Chief Medical Officer & Vice President at Hansa Biopharma AB, Chief Marketing Officer at Idogen AB, and Chief Medical Officer at Ectin Research AB. He holds a doctorate degree from the University of Copenhagen.
Actieve functies van Steven Glazer
| Bedrijven | Functie | Begin |
|---|---|---|
Glazer Consulting Holding ApS | Hoofd Techniek/Wetenschap/O&O | - |
MonTa Biosciences ApS
MonTa Biosciences ApS BiotechnologyHealth Technology Engages in research and development in biotechnology for cancer immunotherapy | Hoofd Techniek/Wetenschap/O&O | - |
Allero Therapeutics BV
Allero Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Develops immunotherapy treatment for allergic and autoimmune diseases | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Steven Glazer
| Bedrijven | Functie | Einde |
|---|---|---|
| CHOSA ONCOLOGY AB | Corporate Officer/Principal | - |
Idogen AB
Idogen AB BiotechnologyHealth Technology Develops cell therapies for treatment of autoimmune diseases | Verkoop & Marketing | - |
| ECTIN RESEARCH AB | Hoofd Techniek/Wetenschap/O&O | - |
Novo Nordisk Scandinavia AB
Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products and services | Hoofd Techniek/Wetenschap/O&O | - |
| ZEALAND PHARMA A/S | Corporate Officer/Principal | - |
Opleiding van Steven Glazer
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
BioInvent International AB
BioInvent International AB BiotechnologyHealth Technology Develops and manufactures immunomodulatory antibodies for cancer treatment | Health Technology |
Zealand Pharma A/S
Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hansa Biopharma AB
Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
Novo Nordisk Scandinavia AB
Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products and services | Health Technology |
Mendus AB
Mendus AB BiotechnologyHealth Technology Develops immunotherapies for therapeutic treatment of cancer | Health Technology |
Idogen AB
Idogen AB BiotechnologyHealth Technology Develops cell therapies for treatment of autoimmune diseases | Health Technology |
RhoVac AB
RhoVac AB BiotechnologyHealth Technology Engages in the research and development of immunotherapy for therapeutic cancer vaccines | Health Technology |
MonTa Biosciences ApS
MonTa Biosciences ApS BiotechnologyHealth Technology Engages in research and development in biotechnology for cancer immunotherapy | Health Technology |
Ectin Research AB
Ectin Research AB BiotechnologyHealth Technology Provides cancer therapy research services | Health Technology |
Allero Therapeutics BV
Allero Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Develops immunotherapy treatment for allergic and autoimmune diseases | Commercial Services |
Glazer Consulting Holding ApS |
















